Leaders in Supply & Demand Side Intelligence

Forgot your login?

Enter the e-mail address you used when you registered an account with IIR Energy.

A message will be sent to the E-Mail Address found in our records containing the associated username(s) as well as instructions for a password reset.

E-Mail:

Pharma/Bio Industry Ramping Up Aseptic Fill/Finish Capacity to Combat Pandemic, an Industrial Info Market Brief

Free News Article
Map
Attachment Included

In the Pharma/Bio Industry, aseptic fill/finish manufacturing is the aseptic filling of biological drugs or medicines in any form, such as sterile liquid, powder and suspension, in vials, ampoules, bottles syringes and cartridges after the product is produced. As such, the sector is anticipated to play a big role in the manufacture of COVID-19 vaccines.

It is not uncommon that a manufacturer does not have fill/finish capabilities on site. Instead, it is a common practice that the bulk drug substance is made by one manufacturer and shipped to a second site, sometimes a contractor, to fill the final drug product.

Details on this Article:
Industry Segment: Market Brief
Word Count: 149 Words
Attachment: Map
Listen to Today's News News Audio Library Sync News Podcasts

Login or Register now for instant access!
Related Articles

FREE ARTICLE

This article is free for all Registered Members.

Register Now! All Fields are Required...



Pricing Help?

Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361

All Members Receive the Following Free Resources:

  • North American Project & Gap Spending
  • North American Plant Analysis by Industry & Market Region
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current & Historic Economic Indicators
  • 30/60/90 Day Weather Forecast